IVIG Therapy for Orth/Musculoskeletal: 50.0% of denials overturned
In 10 California IMR decisions from 2005 to 2023, reviewers overturned 5 (50.0%). In the last five years: 40.0% of 5. 10 were medical-necessity disputes.
By year (last five)
| Year | Decisions | Overturned |
|---|---|---|
| 2021 | 2 | 0.0% |
| 2022 | 2 | 100.0% |
| 2023 | 1 | 0.0% |
What the findings mention
| What the findings mention | Decisions | Overturned | All decisions here |
|---|---|---|---|
| Published evidence citedThe findings refer to peer-reviewed or published evidence. | 4 | 50.0% | 50.0% |
Keyword matches on the reviewer’s findings, not causes. A tag that appears mostly in overturned decisions is worth documenting in an appeal; it is not a guarantee.
From recent overturned decisions
“Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for Gamunex-C intravenous immunoglobulin (IVIG) home infusions. There is a lack of clinical trial data reported to establish effective treatments for the management of patients with statin-triggered autoimmune myopathy. The consensus during the 224th European Neuromuscular Centre (ENMC) International Workshop defined “anti-HMGCR myopathy” in patients with (a) elevated …”
“Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for Gammagard intravenous immunoglobulin infusions (35 grams daily for three days, then 52 grams for one to two days every three to four weeks for one year). Finnerup and colleagues report that inadequate response to drug treatments constitutes a substantial unmet need in patients with neuropathic pain. Liu …”
“Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for intravenous (IV) Reclast 5 mg. Findings: The physician reviewer found that based on the available documentation, this patient has osteopenia on dual energy x-ray absorptiometry (DEXA) scan and her fracture risk score is 6.5%. Previous therapy has included IV zoledronic acid, which the provider noted the patient …”
And one the reviewer upheld
“Nature of Statutory Criteria/Case Summary: The parent of an enrollee has requested authorization and coverage for the medication immune globulin (gamunex-c/gammarked).While the submitted documentation includes a letter from the attending physician requesting approval for monthly IVIG infusions, there are no accompanying, supporting, peer reviewed publications or national guidelines that are cited to support this request.There are two studies from 1993 …”
- California only: these are decisions by independent reviewers under California's IMR program (plans regulated by the Department of Managed Health Care). Other states and self-funded employer plans use different reviewers and rules.
- Selection: only denials that a member took all the way to IMR appear. Most denials are never appealed, and the ones that reach an external reviewer are not a random sample.
- Overturned means the reviewer disagreed with the plan; it does not mean the treatment worked or that a similar request will be approved.
- Argument tags are keyword matches on the reviewer's findings. They describe what the findings mention, not why the case was decided.
- Categories are DMHC's own labels (treatment sub-category and diagnosis category); 'Other' is a catch-all and is excluded from rankings.
Source: California Department of Managed Health Care, Independent Medical Review (IMR) Determinations, Trend (CHHS Open Data). Public California government data; Apellica's aggregates and tags are CC BY 4.0.
Questions
How often were IVIG Therapy denials for Orth/Musculoskeletal overturned?
In 10 California IMR decisions from 2005 to 2023, reviewers overturned 5 (50.0%). In the last five years: 40.0% of 5. 10 were medical-necessity disputes.
What should an appeal document, based on these findings?
Whatever the plan's criteria ask for, shown in the record: the treatments already tried and their results, contraindications to the plan's preferred option, the guideline or evidence that supports the request, and the treating clinician's reasoning written to the criteria. The tag table shows which of these the reviewers mentioned most in overturned cases.
Does a California IMR result apply to my plan?
Only California plans regulated by the Department of Managed Health Care go to IMR. Other states and self-funded employer plans use different reviewers, but they weigh the same things.
Independent reviewers reverse plans when the record answers the criteria. Upload the denial letter; a senior reviewer reads it within 24 hours and tells you in writing whether it can be appealed and how. $0 upfront, 10% of what is recovered, nothing if we do not recover. Not a law firm.